Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07828561
NA

Clinical Outcomes of Intraarticular Platelet-Rich Plasma Injection in Knee Osteoarthritis

Sponsor: KIST Medical and Teaching Hospital

View on ClinicalTrials.gov

Summary

This prospective single-arm interventional study was designed to assess the short-term clinical outcomes of intra-articular platelet-rich plasma (PRP) injections in patients with Kellgren-Lawrence grade II and III knee osteoarthritis. A total of 59 patients (61 knees) were enrolled and followed for six months. Pain and function were measured using the Visual Analogue Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Safety monitoring included documentation of injection-site pain and other adverse events.

Official title: Prospective Interventional Study on Intraarticular Platelet-Rich Plasma Injection in Patients With Kellgren-Lawrence Grade II and III Knee Osteoarthritis

Key Details

Gender

All

Age Range

50 Years - Any

Study Type

INTERVENTIONAL

Enrollment

59

Start Date

2022-11-05

Completion Date

2023-11-05

Last Updated

2026-09-18

Healthy Volunteers

No

Interventions

BIOLOGICAL

Platelet-Rich Plasma (PRP)

Autologous PRP prepared from 16 ml of venous blood using a double-spin centrifugation protocol (first spin \~700 g for 12 minutes, second spin \~1700 g for 7 minutes). The final product was leukocyte-poor PRP with a mean 4.2-fold increase in platelet concentration. A single 5 ml dose was injected intraarticularly via an inferolateral approach using an 18G needle under aseptic precautions.

Locations (1)

KIST Medical College and Teaching Hospital

Lalitpur, Nepal